Susquehanna International Group, LLP Armata Pharmaceuticals, Inc. Call Options Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARMP
# of Institutions
31Shares Held
770KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$626,7750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$251,9550.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$241,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$107,6830.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$97,1230.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $87.1M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...